Patents by Inventor Christopher Liddle

Christopher Liddle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100146652
    Abstract: An isolated nucleic acid molecule comprising a nucleotide sequence encoding a transcriptional enhancer of cytochrome P450 (P450) CYP3A4 production or expression, and uses of the nucleic acid molecule for screening compounds for xenobiotic induction of CYP3A4 expression in cells and animals.
    Type: Application
    Filed: December 2, 2009
    Publication date: June 10, 2010
    Applicant: THE UNIVERSITY OF SYDNEY
    Inventors: Christopher LIDDLE, Bryan James Goodwin
  • Patent number: 7638614
    Abstract: An isolated nucleic acid molecule comprising a nucleotide sequence encoding a transcriptional enhancer of cytochrome P450 (P450) CYP3A4 production or expression, and uses of the nucleic acid molecule for screening compounds for xenobiotic induction of CYP3A4 expression in cells and animals.
    Type: Grant
    Filed: January 4, 2006
    Date of Patent: December 29, 2009
    Assignee: The University of Sydney
    Inventors: Christopher Liddle, Bryan James Goodwin
  • Publication number: 20090307785
    Abstract: The invention relates to the generation of non-human transgenic animals comprising a reporter construct for producing a detectable amount of a reporter molecule operably linked to a transcriptional regulatory nucleic acid molecule from the human CYP3A4 gene located between the initiation of transcription site of the gene and a position located 13,000 nucleotides upstream from the site. The invention also relates to the use of these animals for determining the effect of a compound, particularly, but not exclusively, a xenobiotic or steroid, on the regulation of expression of the CYP3A4 gene in a human.
    Type: Application
    Filed: April 27, 2009
    Publication date: December 10, 2009
    Applicant: The University of Sydney
    Inventors: Christopher Liddle, Bryan James Goodwin, Graham Robertson
  • Publication number: 20090288181
    Abstract: The invention relates to the generation of non-human transgenic animals comprising a reporter construct for producing a detectable amount of a reporter molecule operably linked to a transcriptional regulatory nucleic acid molecule from the human CYP3A4 gene located between the initiation of transcription site of the gene and a position located 13,000 nucleotides upstream from the site. The invention also relates to the use of these animals for determining the effect of a compound, particularly, but not exclusively, a xenobiotic or steroid, on the regulation of expression of the CYP3A4 gene in a human.
    Type: Application
    Filed: May 8, 2009
    Publication date: November 19, 2009
    Applicant: The University of Sydney
    Inventors: Christopher LIDDLE, Bryan James Goodwin, Graham Robertson
  • Publication number: 20090209500
    Abstract: This application relates to methods of treating, preventing, and ameliorating fibrosis, such as fibrosis of the liver, kidney, or pancreas. In particular, the application relates to methods of using a vitamin D receptor agonist (such as vitamin D, vitamin D analogs, vitamin D precursors, and vitamin D receptor agonists precursors) for the treatment of fibrosis. Also disclosed are methods for screening for agents that treat, prevent, and ameliorate fibrosis.
    Type: Application
    Filed: November 6, 2008
    Publication date: August 20, 2009
    Inventors: RONALD M. EVANS, MICHAEL DOWNES, CHRISTOPHER LIDDLE
  • Patent number: 7531712
    Abstract: The invention relates to the generation of non-human transgenic animals comprising a reporter construct for producing a detectable amount of a reporter molecule operably linked to a transcriptional regulatory nucleic acid molecule from the human CYP3A4 gene located between the initiation of transcription site of the gene and a position located 13,000 nucleotides upstream from the site. The invention also relates to the use of these animals for determining the effect of a compound, particularly, but not exclusively, a xenobiotic or steriod, on the regulation of expression of the CYP3A4 gene in a human.
    Type: Grant
    Filed: November 1, 2001
    Date of Patent: May 12, 2009
    Assignee: The University of Syndey
    Inventors: Christopher Liddle, Bryan James Goodwin, Graham Robertson
  • Publication number: 20060105385
    Abstract: An isolated nucleic acid molecule comprising a nucleotide sequence encoding a transcriptional enhancer of cytochrome P450 (P450) CYP3A4 production or expression, and uses of the nucleic acid molecule for screening compounds for xenobiotic induction of CYP3A4 expression in cells and animals.
    Type: Application
    Filed: January 4, 2006
    Publication date: May 18, 2006
    Applicant: The University of Sydney
    Inventors: Christopher Liddle, Bryan Goodwin
  • Patent number: 6984489
    Abstract: An isolated nucleic acid molecule comprising a nucleotide sequence encoding a transcriptional enhancer of cytochrome P450 (P450) CYP3A4 production or expression is disclosed, as are uses of the nucleic acid molecule for screening compounds for xenobiotic induction of CYP3A4 expression in cells and animals.
    Type: Grant
    Filed: May 20, 1999
    Date of Patent: January 10, 2006
    Assignee: The University of Sydney
    Inventors: Christopher Liddle, Bryan James Goodwin
  • Publication number: 20050076397
    Abstract: The invention relates to the generation of non-human transgenic animals comprising a reporter construct for producing a detectable amount of a reporter molecule operably linked to a transcriptional regulatory nucleic acid molecule from the human CYP3A4 gene located between the initiation of transcription site of the gene and a position located 13,000 nucleotides upstream from the site. The invention also relates to the use of these animals for determining the effect of a compound, particularly, but not exclusively, a xenobiotic or steriod, on the regulation of expression of the CYP3A4 gene in a human.
    Type: Application
    Filed: November 1, 2001
    Publication date: April 7, 2005
    Inventors: Christopher Liddle, Bryan Goodwin, Graham Robertson